SUSQUEHANNA INTERNATIONAL GROUP, LLP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$29,695,737
-20.5%
1,871,187
-5.5%
0.01%
-14.3%
Q2 2023$37,352,372
+639.1%
1,979,458
+50.4%
0.01%
+600.0%
Q1 2023$5,053,885
+27.2%
1,316,116
+64.3%
0.00%
Q4 2022$3,973,139
+7.4%
801,036
+3.5%
0.00%
-100.0%
Q3 2022$3,698,000
+92.2%
773,839
+81.0%
0.00%
Q2 2022$1,924,000
-27.6%
427,517
-23.4%
0.00%
Q1 2022$2,658,000
-77.6%
558,285
-65.1%
0.00%
Q4 2021$11,870,000
+127.4%
1,599,612
+73.8%
0.00%
Q3 2021$5,220,000
+45.4%
920,621
+69.0%
0.00%
Q2 2021$3,591,000
+2.5%
544,847
+25.9%
0.00%
Q1 2021$3,504,000
-45.0%
432,677
-56.2%
0.00%
Q4 2020$6,376,000
+448.2%
988,622
+205.8%
0.00%
Q3 2020$1,163,000
+3.9%
323,308
+33.0%
0.00%
Q2 2020$1,119,000
-26.9%
243,131
-45.8%
0.00%
Q1 2020$1,530,000
+12.9%
448,841
+69.1%
0.00%
Q4 2019$1,355,000
+8.7%
265,425
-48.5%
0.00%
Q3 2019$1,246,000
-86.8%
515,209
-88.2%
0.00%
-100.0%
Q2 2019$9,458,000
+40.3%
4,358,921
+75.2%
0.00%
-66.7%
Q1 2019$6,743,000
-5.3%
2,488,258
+67.7%
0.00%0.0%
Q4 2018$7,123,000
+305.4%
1,483,797
+699.5%
0.00%
Q3 2018$1,757,000
-78.1%
185,600
-77.5%
0.00%
-100.0%
Q2 2018$8,035,000
-17.2%
825,774
-10.5%
0.00%
-25.0%
Q1 2018$9,708,000
+421.9%
922,800
+218.0%
0.00%
Q4 2017$1,860,000
-55.3%
290,200
-46.7%
0.00%
-100.0%
Q3 2017$4,163,000
+35.9%
544,109
+26.3%
0.00%
+100.0%
Q2 2017$3,063,000
+187.9%
430,900
+56.7%
0.00%
Q1 2017$1,064,000
-27.1%
275,000
-61.6%
0.00%
Q4 2016$1,459,000
+154.6%
715,384
+234.3%
0.00%
Q3 2016$573,000
-3.0%
213,984
+11.7%
0.00%
Q2 2016$591,000
-79.0%
191,600
-42.1%
0.00%
-100.0%
Q1 2016$2,820,000
-27.7%
330,991
+15.2%
0.00%
-50.0%
Q4 2015$3,900,000
-0.4%
287,384
-29.6%
0.00%
+100.0%
Q3 2015$3,917,000
-33.2%
407,972
-0.0%
0.00%
-66.7%
Q2 2015$5,867,000
+104.9%
408,076
+27.5%
0.00%
+200.0%
Q1 2015$2,864,000
-31.7%
320,096
-53.4%
0.00%0.0%
Q4 2014$4,191,000
+44.8%
687,076
+151.4%
0.00%
Q3 2014$2,894,000
-36.5%
273,276
-28.9%
0.00%
-100.0%
Q2 2014$4,557,000
-34.3%
384,612
-17.2%
0.00%0.0%
Q1 2014$6,931,000
-8.9%
464,254
-10.5%
0.00%
-25.0%
Q4 2013$7,607,000
-18.0%
518,596
-4.8%
0.00%
-20.0%
Q3 2013$9,275,000
+16.8%
544,908
+13.8%
0.01%
+25.0%
Q2 2013$7,941,000478,6700.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders